.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Poster

MSP 161

The antifungal drug luliconazole inhibits the growth and biofilm production of azole-resistant Aspergillus fumigatus in ex vivo and in vivo infection models

Presented in

Molecular Infection Epidemiology and Prediction of Antimicrobial Resistance (FG MS)

Poster topics

Molecular Infection Epidemiology and Prediction of Antimicrobial Resistance (FG MS)

Authors

Dan-Tiberiu Furnica (Essen, DE), Ulrike Scharmann (Essen, DE), Jörg Steinmann (Essen, DE; Nürnberg, DE), Peter-Michael Rath (Essen, DE), Lisa Kirchhoff (Essen, DE)